By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Salesforce Q3 Results: Profitability Powerhouse (NYSE:CRM)
News

Salesforce Q3 Results: Profitability Powerhouse (NYSE:CRM)

News
Last updated: 2023/11/30 at 9:36 AM
By News
Share
9 Min Read
SHARE

Contents
Investment ThesisRapid Recap,Salesforce’s Near-Term ProspectsRevenue Growth Rates Continue to Tick AlongCRM Stock Valuation — Approximately 20x to 23x Next Year’s EPSThe Bottom Line

Investment Thesis

Salesforce (NYSE:CRM) reported fiscal Q3 2024 that took the market by storm. Salesforce hasn’t made it into the coveted club of the magnificent 7. But those catchy names will come and go.

But what I believe will distinguish Salesforce from many of its peers is that this business generates insanely strong cash flows and profits. Yes, clean, post-SBC, GAAP operating profits.

I remain adamant that this investment is cheaply valued and that the stock is priced at approximately 20x to 23x next year’s EPS, thus making it a very attractive stock to buy.

Rapid Recap,

In my previous bullish analysis back in August I said,

Salesforce impresses [by] acquiescing that its growth rates have slowed down, but how AI will deliver tremendous productivity gains, and that “customers [will] begin to adopt these new AI technologies and understand they need to invest and grow to be able to achieve this kind of next level of productivity”.

Simply put, Salesforce makes the argument that there’s still more upside left down the road.

And for my part, I have to say, despite Salesforce being a well-known and highly followed company, I have to say that its valuation of around 20x next year’s EPS is cheap for what it offers.

Author's work on CRM

Author’s work on CRM

With the benefit of hindsight, I was right to turn bullish on Salesforce earlier in 2023 (calendar year, not Salesforce’s fiscal year). But if I’m 100% honest, its performance hadn’t been as strong as I had expected.

However, looking ahead, I believe the stock will catch up, as doubters turn to believers (and buyers).

Salesforce’s Near-Term Prospects

Salesforce’s near-term prospects are promising as the company continues to leverage its comprehensive suite of products and strategic initiatives. The recent strong performance in Q3 underscores Salesforce’s ability to execute and drive consistent, profitable growth.

A significant contributor to this success is the continued momentum of MuleSoft, a key element in Salesforce’s strategy. MuleSoft, a data integration platform, is playing a pivotal role in helping customers bring together disparate data sources, a critical aspect as companies increasingly embark on AI and digital transformation journeys.

The emphasis on data, AI, CRM, and trust, positions Salesforce at the forefront of innovation. Additionally, the company’s multi-cloud approach, evident in nine out of the top ten deals including six or more clouds, reflects the adaptability and scalability of its offerings.

However, amidst the positive outlook, Salesforce faces certain near-term challenges, particularly in the financial domain. While revenue and margin growth have been impressive (more on this soon), there are ongoing considerations noted by some restructuring charges, estimated at $0.91 per share. That being said, I don’t believe investors will be too harsh on that charge, as they’ll rapidly look further ahead to its strong profitable growth, which we discuss next.

Revenue Growth Rates Continue to Tick Along

CRM revenue growth rates

CRM revenue growth rates

In my previous analysis, I said,

There may be some investors who are taken aback at times by Salesforce’s focus on hard rhetoric. It’s not for everyone. But when it came time to step up and deliver, Salesforce did just that and continues to guide towards more growth to come ahead.

I said it then, and it’s worthwhile repeating now, that Salesforce continues to deliver solid growth. Yes, it’s no longer delivering those juicy 20% annual rates, but this isn’t where the story for investors ends. On the contrary, the bull case is found at the bottom of the income statement.

CRM Stock Valuation — Approximately 20x to 23x Next Year’s EPS

Now, we get to the icing on the cake for Salesforce. The business reiterates the message it’s been making clear in the past couple of quarters. This business is going to start to ooze some serious profitability.

Case in point, fiscal Q3 2024 saw its non-GAAP operating profit margin expand 850 basis points compared with the same period a year ago. Not only does this mean that fiscal Q3 2024 saw 31.2% of operating margins, but it now gives one the impression that perhaps 32% to 33% of non-GAAP operating margins are sustainable in fiscal 2025 (next calendar year).

Given all the criticism that Salesforce gets, justifiably, about its lavish stock-based compensation, I believe investors also should be quick to recognize that even on a GAAP basis, there was a strong improvement.

This led Salesforce’s CFO Amy Weaver to state,

We also remain focused on stock-based compensation, which is now expected to be approximately 8% as a percent of revenue.

This means that there’s a possibility that over the next twelve months, Salesforce’s clean GAAP operating margins could be reaching 20%. This would undoubtedly put Salesforce among the highest-quality businesses.

To get some perspective, last year, Salesforce’s non-GAAP EPS was $5.24 and this year it is guided for $8.19 of EPS, up 56% y/y. Although, I don’t believe that expecting this sort of growth of strong EPS next year is on the cards, nor should we expect it to be as strong.

But I do believe that around a 30% y/y increase in EPS is possible given management’s newly found focus to tighten up its cost structure, which should deliver about $10.70 of EPS in fiscal 2025 (next calendar year).

This implies that the stock is priced at about 23x next year’s EPS. On top of that, there’s also some more room for Salesforce to repurchase its stock next year. As a reference point, this is what CFO Weaver said on the call,

[…] As we focus on shareholder return and disciplined capital allocation, we continue to expect to fully offset our stock-based compensation dilution through our share repurchases in fiscal year ’24.

In fact, as a result of our ongoing share repurchases, for the first time in company history, we expect the full year’s ending share count to decrease year-over-year.

Altogether, I believe that including buybacks, Salesforce could be priced at somewhere around 20x to 23x next year’s EPS.

The Bottom Line

In conclusion, Salesforce’s near-term prospects are marked by the company’s strategic initiatives and robust product portfolio. The strong performance in Q3, fueled by the continued momentum of MuleSoft, underscores Salesforce’s ability to drive consistent, profitable growth.

Turning to valuation, Salesforce’s stock is attractively priced, ranging from approximately 20x to 23x next year’s EPS. The company’s focus on profitability is evident in the expansion of non-GAAP operating margins, reaching 31.2% in fiscal Q3, representing an 850 basis point increase year-over-year. The expectation of stock-based compensation being around 8% as a percentage of revenue signals prudent financial management, something investors have long asked for.

With the potential for clean GAAP operating margins to reach around 20%, Salesforce stands out as a very high-quality business. The anticipation of continued growth, coupled with disciplined capital allocation and share repurchases, positions the stock favorably, making it an appealing investment opportunity.

Read the full article here

News November 30, 2023 November 30, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Politics And The Markets 07/08/25

By News
News

CGDG ETF: A Global Dividend Grower With Active Edge And Smart Diversification

By News
News

3 Strong, Diversified Bond ETFs – One Stands Out: BINC, CARY, And CGMS (NYSEARCA:BINC)

By News
News

Sell Your CoreWeave (NASDAQ:CRWV) | Seeking Alpha

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?